Eli Lilly (LLY) EV to EBITDA (2009 - 2026)
Eli Lilly's EV to EBITDA was 27.81 in Q2 2026, down 9.6% from 30.76 a year earlier but up 14.6% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EV to EBITDA (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eli Lilly's EV to EBITDA was 27.25 through Jun 30, 2026, down 10.2% year-over-year; for FY2025, it came in at 32.25, down 20.6% from FY2024.
- In earlier years, EV to EBITDA was 40.60 in FY2024 (-13.2%), 46.76 in FY2023 (+29.3%), 36.15 in FY2022 (+23.7%) and 29.22 in FY2021 (+50.4%).
- Quarterly EV to EBITDA has moved between 24.26 (Q1 2026) and 58.97 (Q2 2024) over five years.
- Compared with a year earlier, EV to EBITDA has declined for seven straight quarters, with an average decline of 24.7% over the last eight quarters.
- The best year-over-year quarter for EV to EBITDA over five years was Q2 2023 (growth of 63.0%); the worst was Q3 2025 (a decline of 52.1%).
- Per Business Quant data, LLY's EV to EBITDA in the three quarters before Q2 2026 was 24.26 (Q1 2026), 32.25 (Q4 2025) and 25.83 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.81 |
| Mar 31, 2026 | 24.26 |
| Dec 31, 2025 | 32.25 |
| Sep 30, 2025 | 25.83 |
| Jun 30, 2025 | 30.76 |
| Mar 31, 2025 | 37.74 |
| Dec 31, 2024 | 40.60 |
| Sep 30, 2024 | 53.97 |
| Jun 30, 2024 | 58.97 |
| Mar 31, 2024 | 57.38 |
| Dec 31, 2023 | 46.76 |
| Sep 30, 2023 | 46.82 |
| Jun 30, 2023 | 48.60 |
| Mar 31, 2023 | 37.87 |
| Dec 31, 2022 | 36.15 |
| Sep 30, 2022 | 30.74 |
| Jun 30, 2022 | 29.81 |
| Mar 31, 2022 | 26.80 |
| Dec 31, 2021 | 29.22 |
| Sep 30, 2021 | 24.40 |
API Access
Eli Lilly EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();